The invention encompasses compounds of Formula (I), including pharmaceutically acceptable salts and solvates, their pharmaceutical compositions, and their use in treating disorders associated with an excess or imbalance of tachykinins or serotonin or both.
申请公布号
WO2006014942(A1)
申请公布日期
2006.02.09
申请号
WO2005US26466
申请日期
2005.07.26
申请人
BRISTOL-MYERS SQUIBB COMPANY;HUANG, YAZHONG;HU, SHUANGHUA;DEGNAN, ANDREW, P.
